Coherus BioSciences Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
Thank you all for joining Day 3 of the Bank of America Health Care Conference. Up next, we have Coherus BioScience.
Presenting will be Denny Lanfear, CEO. This is Chris McCarthy speaking from the equity sales and trading desk. I'm a specialty salesperson in health care. Denny will be presenting, but you can ask questions via Veracast which, if there are any at the end, we will post to management.
Denny, thanks so much.
Thank you very much. Let me first start my remarks indicating that all statements made by the company are forward-looking statements. They are subject to the customary qualifications and all statements made are subject to the company's SEC filings, including our most recent. Thank you.
So let me first talk a little bit about the company's position with UDENYCA, which has been the most successful biosimilar product to date and how the company intends to leverage the success of UDENYCA across a broad range of other biosimilars over the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
